Dataset Information

Prevalence and incidence of sarcoidosis in Korea: a nationwide population-based study.

ABSTRACT:

Background

The prevalence and incidence of sarcoidosis varies worldwide. We estimated the prevalence and incidence of sarcoidosis in Korea using nationwide claims data from the Korean Health Insurance Review and Assessment Service.

Methods

Cases of sarcoidosis were identified for any visit between 2007 to 2016 that listed the Korean Classification of Disease, 7th edition code of sarcoidosis and rare incurable disease exempted calculation code. A narrow case definition was used as follows: 1)???two sarcoidosis-coded visits within 1 year of the first claim, 2) no claims for other diseases that could form granuloma.

Results

A total of 4791 patients (narrow, n?=?2388) visited medical institutions for sarcoidosis during the study period; 2999 patients (narrow, n?=?1696) were newly identified between 2009 and 2015. The sarcoidosis prevalence was 9.37 per 10⁵ people (narrow, 4.69) and was highest between ages 60-69 years. The incidence rate was 0.85 per 10⁵ population at risk (narrow, 0.48), with the highest incidence rate between ages 50-59 years. For incident cases (mean age: 48.5 year), the age distribution in whole population and females showed monophasic patterns peaking at aged 50-59 years, while males had biphasic incidence peak at aged 30-39 years and 60-69 years. The annual incidence rates showed increasing trends from 0.85 per 10⁵ population at risk in 2009 to 0.97 per 10⁵ population at risk in 2015.

Conclusions

In comparison with previous reports, the prevalence and incidence of sarcoidosis in Korea have increased and middle-aged women showed the highest risk.

SUBMITTER: Yoon HY

PROVIDER: S-EPMC6114796 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Prevalence and incidence of sarcoidosis in Korea: a nationwide population-based study.

Yoon Hee-Young HY Kim Hyeong Min HM Kim Ye-Jee YJ Song Jin Woo JW

Respiratory research 20180828 1

<h4>Background</h4>The prevalence and incidence of sarcoidosis varies worldwide. We estimated the prevalence and incidence of sarcoidosis in Korea using nationwide claims data from the Korean Health Insurance Review and Assessment Service.<h4>Methods</h4>Cases of sarcoidosis were identified for any visit between 2007 to 2016 that listed the Korean Classification of Disease, 7th edition code of sarcoidosis and rare incurable disease exempted calculation code. A narrow case definition was used as ...[more]

PMID: 30153830

Similar Datasets

Project description:BackgroundAtherosclerotic cardiovascular disease (ASCVD) is the leading cause of death in Korea. According to a report of published by Statistics Korea in 2014, cerebrovascular disease and cardiovascular disease were the major/leading causes of mortality. However, it is more difficult to identify prevalence and incidence of a disease than the mortality owing to the lack of national-level statistics. Few studies have examined the prevalence and incidence of ASCVD and its risk factors since 2012. This study aimed to estimate the prevalence and incidence of ASCVD and its risk factors in Korea using national claims data.MethodsWe conducted a retrospective analysis using the national claims data of the Health Insurance Review and Assessment Service. Patients aged ≥18 years with ASCVD (defined as myocardial infarction, angina, coronary revascularization, peripheral artery disease, ischemic stroke, and transient ischemic attack) were identified between January 1, 2014 and December 31, 2015. Patients at high risk for ASCVD (defined as hypertension, diabetes mellitus, and dyslipidemia without ASCVD during the baseline period) were identified between January 1, 2015 and December 31, 2015. We estimated the prevalence, cumulative incidence, and incidence density. These were further stratified by age and sex. The respective denominators for prevalence and incidence were the census population and the at-risk population (defined as the population without respective disease 1 year prior to the respective disease identification).ResultsAmong the included Korean adult patients, the overall prevalence of clinical ASCVD per 1000 individuals was 98.25 in 2014 and 101.11 in 2015. The respective cumulative incidence and incidence density rates of ASCVD per 1000 individuals were 65.30 and 68.03 in 2014, and 67.05 and 69.94 in 2015, respectively. Peripheral artery disease seemed to drive the increase in the total prevalence and incidence of ASCVD. The prevalence and incidence of ASCVD continued to increase with age until 79 years.ConclusionsThis national population-based study confirmed the high prevalence and incidence of ASCVD and its risk factors in the adult population of South Korea. We suggest that more intensive treatment and prevention are needed to prevent ASCVD.

Dataset Information

Prevalence and incidence of sarcoidosis in Korea: a nationwide population-based study.

Background

Methods

Results

Conclusions

Publications

Prevalence and incidence of sarcoidosis in Korea: a nationwide population-based study.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure